| 763728 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Dendritic cell vaccines targeting tumor blood vessel antigens in combination with dasatinib induce therapeutic immune responses in patients with checkpoint-refractory advanced melanoma |
2021-11-01 |
10.1136/jitc-2021-003675 |
Storkus Walter J, Maurer Deena, Lin Yan, Ding Fei, Bose Anamika, Lowe Devin, Rose Amy, DeMark Melissa, Karapetyan Lilit, Taylor Jennifer L, Chelvanambi Manoj, Fecek Ronald J, Filderman Jessica N, Looney Timothy J, Miller Lauren, Linch Elizabeth, Lowman Geoffrey M, Kalinski Pawel, Butterfield Lisa H, Tarhini Ahmad, Tawbi Hussein, Kirkwood John M |
| 763727 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Combining CTLA-4 and angiopoietin-2 blockade in patients with advanced melanoma: a phase I trial |
2021-11-01 |
10.1136/jitc-2021-003318 |
Ott Patrick A, Nazzaro Matthew, Pfaff Kathleen L, Gjini Evisa, Felt Kristen D, Wolff Jacquelyn O, Buchbinder Elizabeth I, Haq Rizwan, Sullivan Ryan J, Lawrence Donald P, McDermott David F, Severgnini Mariano, Giobbie-Hurder Anita, Rodig Scott J, Stephen Hodi F |
| 763726 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication |
2021-11-01 |
10.1136/jitc-2021-003293 |
Van Den Eeckhout Bram, Huyghe Leander, Van Lint Sandra, Burg Elianne, Plaisance Stéphane, Peelman Frank, Cauwels Anje, Uzé Gilles, Kley Niko, Gerlo Sarah, Tavernier Jan |
| 763725 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Synergy between Toxoplasma gondii type I ΔGRA17 immunotherapy and PD-L1 checkpoint inhibition triggers the regression of targeted and distal tumors |
2021-11-01 |
10.1136/jitc-2021-002970 |
Zhu Yu-Chao, Elsheikha Hany M, Wang Jian-Hua, Fang Shuai, He Jun-Jun, Zhu Xing-Quan, Chen Jia |
| 763724 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Phase II, single-arm trial of preoperative short-course radiotherapy followed by chemotherapy and camrelizumab in locally advanced rectal cancer |
2021-11-01 |
10.1136/jitc-2021-003554 |
Lin Zhenyu, Cai Ming, Zhang Peng, Li Gang, Liu Tao, Li Xin, Cai Kailin, Nie Xiu, Wang Jing, Liu Junli, Liu Hongli, Zhang Weikang, Gao Jingbo, Wu Chuanqing, Wang Linfang, Fan Jun, Zhang Lan, Wang Zheng, Hou Zhiguo, Ma Chi, Yang Kunyu, Wu Gang, Tao Kaixiong, Zhang Tao |
| 763723 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Synergistic antitumor activity of pan-PI3K inhibition and immune checkpoint blockade in bladder cancer |
2021-11-01 |
10.1136/jitc-2021-002917 |
Zhu Shaoming, Ma A-Hong, Zhu Zheng, Adib Elio, Rao Ting, Li Na, Ni Kaiyuan, Chittepu Veera Chandra Sekhar Reddy, Prabhala Rao, Garisto Risco Juan, Kwiatkowski David, Mouw Kent, Sonpavde Guru, Cheng Fan, Pan Chong-xian |
| 763722 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Letter to the editor from Pant et al |
2021-11-01 |
10.1136/jitc-2021-003991 |
Pant Shubham, Moyers Justin T, Naing Aung |
| 763721 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
Correction: GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors |
2021-11-01 |
10.1136/jitc-2021-003005corr1 |
|
| 763720 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
463 Vibostolimab plus pembrolizumab with/without docetaxel vs docetaxel in NSCLC after platinum chemotherapy and immunotherapy |
2021-11-01 |
10.1136/jitc-2021-sitc2021.463 |
Peters Solange, Lee Dae Ho, Ramlau Rodryg, Halmos Balazs, Schumann Christian, Planchard David, Bhagwati Niyati, Chen Diana (Qiusheng), Kush Debra, Novello Silvia |
| 763719 |
JOURNAL FOR IMMUNOTHERAPY OF CANCER |
655 Landscape of helper and regulatory CD4+ T cells in melanoma |
2021-11-01 |
10.1136/jitc-2021-sitc2021.655 |
Oliveira Giacomo, Stromhaug Kari, Klaeger Susan, Cieri Nicoletta, Iorgulescu Bryan, Li Shuqiang, Braun David, Neuberg Donna, Carr Steven, Livak Kenneth, Tompers Dennie, Fritsch Edward, Wind-Rotolo Megan, Hacohen Nir, Sade-Feldman Moshe, Keskin Derin, Ott Patrick, Rodig Scott, Boland Genevive, Wu Catherine |
